K. Vannice

发表

The Association between Intentional Delay of Vaccine Administration and Timely Childhood Vaccination Coverage

S. Humiston, D. Salmon, Philip J. Smith, 2010, Public health reports.

Immunization-Safety Monitoring Systems for the 2009 H1N1 Monovalent Influenza Vaccination Program

Aysha Akhtar, Patrick Garman, Bruce Gellin, 2011, Pediatrics.

Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency.

A. Barrett, D. Kaslow, J. Hombach, 2016, Vaccine.

Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance.

W Katherine Yih, Richard Platt, Robert Rosofsky, 2012, Health affairs.

Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines

S. Black, N. Andrews, J. Eskola, 2009, The Lancet.

Attitudes and Beliefs of Parents Concerned About Vaccines: Impact of Timing of Immunization Information

S. Omer, K. Edwards, C. Dekker, 2011, Pediatrics.

Live-attenuated tetravalent dengue vaccines: The needs and challenges of post-licensure evaluation of vaccine safety and effectiveness.

I. Longini, Peter G. Smith, A. Lopez, 2017, Vaccine.

Developing evidence-based immunization recommendations and GRADE.

H. Rees, Z. Bhutta, D. Durrheim, 2012, Vaccine.

Pivotal Shigella Vaccine Efficacy Trials—Study Design Considerations from a Shigella Vaccine Trial Design Working Group

G. Kang, C. Deal, J. Platts-Mills, 2022, Vaccines.

Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates

A. Wilder-Smith, J. Hombach, M. Cavaleri, 2019, Vaccine.

MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines

Graham V. Brown, V. Moorthy, K. Vannice, 2012, Malaria Journal.

The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control

A. Barrett, I. Ogbuanu, S. Hills, 2021, NPJ vaccines.

Assessing dengue vaccination impact: Model challenges and future directions.

M. Jit, C. Simmons, J. Hombach, 2016, Vaccine.

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study

Mario Recker, Katia Koelle, Derek A T Cummings, 2016, PLoS medicine.

Zika vaccines and therapeutics: landscape analysis and challenges ahead

Stephen J. Thomas, A. Wilder-Smith, C. Simmons, 2018, BMC Medicine.

Fractional-Dose Yellow Fever Vaccination - Advancing the Evidence Base.

A. Wilder-Smith, J. Hombach, K. Vannice, 2018, The New England journal of medicine.

Typhoid in India: An Age-old Problem With an Existing Solution

Supriya Kumar, K. Vannice, H. Iyer, 2021, The Journal of infectious diseases.

Japanese Encephalitis Surveillance and Immunization — Asia and Western Pacific Regions, 2016

S. Chu, S. Hills, N. Batmunkh, 2017, MMWR. Morbidity and mortality weekly report.

Next generation dengue vaccines: A review of the preclinical development pipeline.

J. Roehrig, J. Hombach, K. Vannice, 2015, Vaccine.

Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine.

A. Barrett, M. Guzmán, J. Farrar, 2019, The Lancet. Infectious diseases.

Rationale for WHO's New Position Calling for Prompt Reporting and Public Disclosure of Interventional Clinical Trial Results

M. Kieny, V. Moorthy, K. Vannice, 2015, PLoS medicine.

Status of vaccine research and development of vaccines for dengue.

J. Hombach, A. Durbin, K. Vannice, 2016, Vaccine.

Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine.

J. Farrar, A. Wilder-Smith, J. Hombach, 2016, The Journal of infectious diseases.

Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.

Eva Harris, Marco Cavaleri, A. Barrett, 2018, Vaccine.

Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010–2013

F. Diomandé, M. Djingarey, M. Préziosi, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The value of multi-country joint regulatory reviews: The experience of a WHO joint technical consultation on the CYD-TDV (Dengvaxia®) dossier.

J. Hombach, M. Pfleiderer, I. Yoon, 2017, Vaccine.

Japanese Encephalitis Surveillance and Immunization — Asia and Western Pacific Regions, 2016

S. Chu, S. Hills, N. Batmunkh, 2017, Morbidity and Mortality Weekly Report.

Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali

L. Moulton, S. Omer, N. Halsey, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines

S. Black, N. Andrews, J. Eskola, 2009, The Lancet.

Consequences of Shigella infection in young children: a systematic review

P. Pavlinac, K. Vannice, C. MacLennan, 2023, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.